297 related articles for article (PubMed ID: 32325700)
21. Molecular biomarkers for prediction of response to treatment and survival in triple negative breast cancer patients from Egypt.
Bahnassy A; Mohanad M; Ismail MF; Shaarawy S; El-Bastawisy A; Zekri AR
Exp Mol Pathol; 2015 Oct; 99(2):303-11. PubMed ID: 26232605
[TBL] [Abstract][Full Text] [Related]
22. RBCK1 is an endogenous inhibitor for triple negative breast cancer via hippo/YAP axis.
Li Z; Su P; Ding Y; Gao H; Yang H; Li X; Yang X; Xia Y; Zhang C; Fu M; Wang D; Zhang Y; Zhuo S; Zhu J; Zhuang T
Cell Commun Signal; 2022 Oct; 20(1):164. PubMed ID: 36280829
[TBL] [Abstract][Full Text] [Related]
23. Overexpression of the miR-141/200c cluster promotes the migratory and invasive ability of triple-negative breast cancer cells through the activation of the FAK and PI3K/AKT signaling pathways by secreting VEGF-A.
Choi SK; Kim HS; Jin T; Hwang EH; Jung M; Moon WK
BMC Cancer; 2016 Aug; 16():570. PubMed ID: 27484639
[TBL] [Abstract][Full Text] [Related]
24. WBP2 Downregulation Inhibits Proliferation by Blocking YAP Transcription and the EGFR/PI3K/Akt Signaling Pathway in Triple Negative Breast Cancer.
Song H; Wu T; Xie D; Li D; Hua K; Hu J; Fang L
Cell Physiol Biochem; 2018; 48(5):1968-1982. PubMed ID: 30092563
[TBL] [Abstract][Full Text] [Related]
25. SASH1 suppresses triple-negative breast cancer cell invasion through YAP-ARHGAP42-actin axis.
Jiang K; Liu P; Xu H; Liang D; Fang K; Du S; Cheng W; Ye L; Liu T; Zhang X; Gong P; Shao S; Wang Y; Meng S
Oncogene; 2020 Jul; 39(27):5015-5030. PubMed ID: 32523092
[TBL] [Abstract][Full Text] [Related]
26. GPER/Hippo-YAP signal is involved in Bisphenol S induced migration of triple negative breast cancer (TNBC) cells.
Deng Q; Jiang G; Wu Y; Li J; Liang W; Chen L; Su Q; Li W; Du J; Wong CKC; Chen Z; Wang H
J Hazard Mater; 2018 Aug; 355():1-9. PubMed ID: 29758456
[TBL] [Abstract][Full Text] [Related]
27. Transforming growth factor-β, insulin-like growth factor I/insulin-like growth factor I receptor and vascular endothelial growth factor-A: prognostic and predictive markers in triple-negative and non-triple-negative breast cancer.
Bahhnassy A; Mohanad M; Shaarawy S; Ismail MF; El-Bastawisy A; Ashmawy AM; Zekri AR
Mol Med Rep; 2015 Jul; 12(1):851-64. PubMed ID: 25824321
[TBL] [Abstract][Full Text] [Related]
28. Correction: Rigiracciolo, D.C., et al., IGF-1/IGF-1R/FAK/YAP Transduction Signaling Prompts Growth Effects in Triple-Negative Breast Cancer (TNBC) Cells.
Rigiracciolo DC; Nohata N; Lappano R; Cirillo F; Talia M; Scordamaglia D; Gutkind JS; Maggiolini M
Cells; 2020 Dec; 9(12):. PubMed ID: 33291355
[TBL] [Abstract][Full Text] [Related]
29. Histone deacetylase 8 triggers the migration of triple negative breast cancer cells via regulation of YAP signals.
An P; Li J; Lu L; Wu Y; Ling Y; Du J; Chen Z; Wang H
Eur J Pharmacol; 2019 Feb; 845():16-23. PubMed ID: 30582912
[TBL] [Abstract][Full Text] [Related]
30. Tinagl1 Suppresses Triple-Negative Breast Cancer Progression and Metastasis by Simultaneously Inhibiting Integrin/FAK and EGFR Signaling.
Shen M; Jiang YZ; Wei Y; Ell B; Sheng X; Esposito M; Kang J; Hang X; Zheng H; Rowicki M; Zhang L; Shih WJ; Celià-Terrassa T; Liu Y; Cristea I; Shao ZM; Kang Y
Cancer Cell; 2019 Jan; 35(1):64-80.e7. PubMed ID: 30612941
[TBL] [Abstract][Full Text] [Related]
31. Insulin-like growth factors are essential to prevent anoikis in oestrogen-responsive breast cancer cells: importance of the type I IGF receptor and PI3-kinase/Akt pathway.
Luey BC; May FE
Mol Cancer; 2016 Jan; 15():8. PubMed ID: 26801096
[TBL] [Abstract][Full Text] [Related]
32. COL8A1 facilitates the growth of triple-negative breast cancer via FAK/Src activation.
Sato F; Sagara A; Tajima K; Miura S; Inaba K; Ando Y; Oku T; Murakami T; Kato Y; Yumoto T
Breast Cancer Res Treat; 2022 Jul; 194(2):243-256. PubMed ID: 35624176
[TBL] [Abstract][Full Text] [Related]
33. Hypoxia-induced YAP activation and focal adhesion turnover to promote cell migration in mesenchymal TNBC cells.
Nguyen TMH; Lai YS; Chen YC; Lin TC; Nguyen NT; Chiu WT
Cancer Med; 2023 Apr; 12(8):9723-9737. PubMed ID: 36757143
[TBL] [Abstract][Full Text] [Related]
34. Paracrine recruitment and activation of fibroblasts by c-Myc expressing breast epithelial cells through the IGFs/IGF-1R axis.
De Vincenzo A; Belli S; Franco P; Telesca M; Iaccarino I; Botti G; Carriero MV; Ranson M; Stoppelli MP
Int J Cancer; 2019 Nov; 145(10):2827-2839. PubMed ID: 31381136
[TBL] [Abstract][Full Text] [Related]
35. Specific activation of insulin-like growth factor-1 receptor by ginsenoside Rg5 promotes angiogenesis and vasorelaxation.
Cho YL; Hur SM; Kim JY; Kim JH; Lee DK; Choe J; Won MH; Ha KS; Jeoung D; Han S; Ryoo S; Lee H; Min JK; Kwon YG; Kim DH; Kim YM
J Biol Chem; 2015 Jan; 290(1):467-77. PubMed ID: 25391655
[TBL] [Abstract][Full Text] [Related]
36.
Solomon VR; Alizadeh E; Bernhard W; Hartimath SV; Hill W; Chekol R; Barreto KM; Geyer CR; Fonge H
Mol Pharm; 2019 Dec; 16(12):4807-4816. PubMed ID: 31518138
[TBL] [Abstract][Full Text] [Related]
37. Stromal EGF and igf-I together modulate plasticity of disseminated triple-negative breast tumors.
Castaño Z; Marsh T; Tadipatri R; Kuznetsov HS; Al-Shahrour F; Paktinat M; Greene-Colozzi A; Nilsson B; Richardson AL; McAllister SS
Cancer Discov; 2013 Aug; 3(8):922-35. PubMed ID: 23689072
[TBL] [Abstract][Full Text] [Related]
38. IGF-1R/YAP signaling pathway is involved in collagen V-induced insulin biosynthesis and secretion in rat islet INS-1 cells.
Zhu Y; Chen S; Liu W; Xu F; Lu J; Hayashi T; Mizuno K; Hattori S; Fujisaki H; Ikejima T
Connect Tissue Res; 2022 Sep; 63(5):498-513. PubMed ID: 35129018
[TBL] [Abstract][Full Text] [Related]
39. Controlled Signaling-Insulin-Like Growth Factor Receptor Endocytosis and Presence at Intracellular Compartments.
Rieger L; O'Connor R
Front Endocrinol (Lausanne); 2020; 11():620013. PubMed ID: 33584548
[TBL] [Abstract][Full Text] [Related]
40. FAK tyrosine 407 organized with integrin αVβ5 in Hs578Ts(i)8 advanced triple-negative breast cancer cells.
Payan I; McDonnell S; Torres HM; Steelant WF; Van Slambrouck S
Int J Oncol; 2016 May; 48(5):2043-54. PubMed ID: 26984508
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
